NASDAQ:MBOT - Microbot Medical Stock Price, Forecast & News

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

Shares of Microbot Medical reverse split on the morning of Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

Microbot Medical Inc (NASDAQ:MBOT) announced its quarterly earnings results on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.60) by $0.02. View Microbot Medical's Earnings History.

Microbot Medical is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Microbot Medical.

1 brokerages have issued 1 year price targets for Microbot Medical's shares. Their forecasts range from $26.00 to $26.00. On average, they expect Microbot Medical's share price to reach $26.00 in the next year. This suggests a possible upside of 191.8% from the stock's current price. View Analyst Price Targets for Microbot Medical.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Microbot Medical.

Media coverage about MBOT stock has trended neutral on Sunday, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Microbot Medical earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Microbot Medical.

Microbot Medical saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 430,700 shares, an increase of 202.2% from the December 31st total of 142,500 shares. Based on an average trading volume of 1,140,000 shares, the days-to-cover ratio is presently 0.4 days. Approximately 10.1% of the company's stock are sold short. View Microbot Medical's Current Options Chain.

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Novavax (NVAX), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Sarepta Therapeutics (SRPT), NovaBay Pharmaceuticals (NBY), Inovio Pharmaceuticals (INO) and Micron Technology (MU).

Microbot Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (3.00%) and Virtu Financial LLC (0.95%). View Institutional Ownership Trends for Microbot Medical.

MBOT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Microbot Medical.

MBOT stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View Insider Buying and Selling for Microbot Medical.

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MBOT stock can currently be purchased for approximately $8.91.